Research / IVDA / Fundamental state Inspectable configuration
State dimensions Filing 0001493152-26-014179 General Corporate
Debt relative to revenue 13th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.debt_to_revenue
7.45% · OPTIONAL · VALID
Operating cash generation 74th Own-history percentile · N=19
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-38.40% · OPTIONAL · VALID
Revenue growth 31th Own-history percentile · N=13
Evidence method Yoy · gp.fundamentals.revenue
-12.30% · CORE · VALID
Inventory pressure 5th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
4.47% · OPTIONAL · VALID
Gross margin 50th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
24.11% · CORE · VALID
Operating margin 55th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
-61.11% · CORE · VALID
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
3.23% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity 85th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
7.12% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 24 states Self-history eligible
Dec 31, 2021 0/7 normalized Level 3 Mar 31, 2022 0/7 normalized Level 3 Jun 30, 2022 0/7 normalized Level 3 Sep 30, 2022 0/8 normalized Level 3 Dec 31, 2022 3/8 normalized Level 3 Mar 31, 2023 6/8 normalized Level 3 Jun 30, 2023 4/6 normalized Level 3 Sep 30, 2023 5/6 normalized Level 3 Dec 31, 2023 6/7 normalized Level 3 Mar 31, 2024 6/7 normalized Level 3 Jun 30, 2024 7/8 normalized Level 3 Sep 30, 2024 8/8 normalized Level 3 Dec 31, 2024 8/9 normalized Level 3 Mar 31, 2025 6/7 normalized Level 3 Dec 31, 2024 7/8 normalized Amended as filed Jun 30, 2025 6/7 normalized Level 3 Sep 30, 2025 6/7 normalized Level 3 Dec 31, 2025 7/8 normalized Level 3 Mar 31, 2026 7/8 normalized Level 3 Jun 30, 2026 7/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 18.55%
Current 7.45%
Delta -11.10% Cash Generation Decreased
Previous -19.19%
Current -38.40%
Delta -19.21% Growth Increased
Previous -31.12%
Current -12.30%
Delta 18.83% Inventory Pressure Decreased
Previous 14.98%
Current 4.47%
Delta -10.52% Margin Decreased
Previous 31.32%
Current 24.11%
Delta -7.21% Profitability Decreased
Previous -12.97%
Current -61.11%
Delta -48.14% R And D Intensity Increased
Previous 1.56%
Current 3.23%
Delta 1.68% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.